Of the nine proteins that showed decline in serum level after surgery, GATA-4, PON1, CEACAM-1 and DSCAM have already been studied in pancreatic cancer and were found to be associated with immune suppression, aggressive phenotype, cancer progression and/or metastasis28–31. The gene discussed is GATA4; the disease is familial pancreatic carcinoma.